There are 2789 resources available
222P - Inflammatory breast cancer: What information we can expect from MRI and how to use it
Presenter: Bibiana Vertakova Krakovska
Session: ePoster Display
223P - Pregnancy-associated breast cancer: A single centre experience
Presenter: Isa Peixoto
Session: ePoster Display
224P - Value of bone scintigraphy in breast cancer patients staged with computed tomography
Presenter: Vladislav Evseev
Session: ePoster Display
225P - Prognostic factors of luminal A and luminal B intrinsic breast cancer subtypes of Croatian patients: A 5-year experience from Osijek
Presenter: Raffaella Gudelj
Session: ePoster Display
Resources:
Abstract
226P - Elderly breast cancer treated with standard curative intent treatment: An analysis of predictors of disease-free survival (DFS)
Presenter: Sai Kumar Soman
Session: ePoster Display
227P - Risk of breast cancer understaging through standard clinical and radiographic staging in Botswana
Presenter: Isaac Nkele
Session: ePoster Display
231P - Prognosis and efficacy of frontline treatment for HR+ HER2- metastatic breast cancer occurring in gBRCA1/2 carriers
Presenter: Jean-Sebastien Frenel
Session: ePoster Display
232P - Longitudinal circulating tumor DNA (ctDNA) analysis in the phase 1b MONALEESASIA study of ribociclib (RIB) + endocrine therapy (ET) in Asian patients (pts) with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC)
Presenter: Yoon Sim Yap
Session: ePoster Display
308P - FDG-PET/CT versus CE-CT for response monitoring in metastatic breast cancer: A prospective comparative study
Presenter: Marianne Vogsen
Session: ePoster Display
309P - Antineoplastic (ANP) therapies (Tx) after alpelisib (ALP) or placebo (PBO) + fulvestrant (FUL) in patients (Pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–), PIK3CA-mutated (Mut) advanced breast cancer (ABC): An analysis from SOLAR-1
Presenter: Fabrice André
Session: ePoster Display